Axsome Therapeutics (AXSM)
(Delayed Data from NSDQ)
$91.31 USD
-0.25 (-0.27%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $91.29 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-1.36 | -4.75% |
Earnings Summary
For their last quarter, Axsome Therapeutics (AXSM) reported earnings of -$1.24 per share, beating the Zacks Consensus Estimate of $-1.30 per share. This reflects a positive earnings surprise of 4.62%. Look out for AXSM's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$1.36 per share, reflecting a year-over-year decrease of 3.03%.
Earnings History
Price & Consensus
Zacks News for AXSM
FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
AXSM: What are Zacks experts saying now?
Zacks Private Portfolio Services